Back to Search
JORDAN ANGELL, MD
MD
Urology Physician
NPI: 1306021076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
35098754(OH)D0075473(MD)
Education
OTHER
Class of 2007
Research & Publications (8)
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.
PMID 18312448·Clin Genet·2008
8-other
Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease.
PMID 17539908·Clin Genet·2007
3-trial
WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
PMID 12671053·J Clin Invest·2003
7-preclinical
Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.
PMID 12433281·J Interferon Cytokine Res·2002
7-preclinical
Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.
PMID 12163600·J Virol·2002
7-preclinical
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase.
PMID 11331281·J Biol Chem·2001
7-preclinical
Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.
PMID 10926209·J Interferon Cytokine Res·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3407 WILKENS AVE STE 200
BALTIMORE, MD 21229 - Phone
- (410) 644-0929
Quick Facts
- NPI
- 1306021076
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 19
- Publications
- 8
Are you this provider?
Claim Your Profile